Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent ...

The first randomised controlled trial of microdosing LSD as a treatment for ADHD found the psychedelic drug wasn’t any more ...

The researchers were prompted to engage in the study due to the anecdotal claims that microdosing LSD alleviated ADHD ...

The LSD dose was well tolerated, with no serious adverse events, but did not improve symptoms over placebo on any of the ...

The perceived benefits of microdosing for attention-deficit/hyperactivity disorder (ADHD) may stem more from expectation than from actual pharmacological effects ...

Microdosing psychedelics, typically lysergic acid diethylamide (LSD) or psilocybin, has recently gathered attention for its potential to improve mental health. Although self-reported benefits ...

While microdosing LSD is being cautiously explored for therapeutic benefit again, it’s probably not going to help with your ...

below). Microdosing the drugs has even been touted for extending longevity by ultra-wealthy elites like tech entrepreneur Bryan Johnson, and is rumoured to be the secret weapon of Hollywood stars ...

The latest microdosing trend isn’t shrooms or acid. It’s Ozempic. The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...

Matthias Liechti at the University of Basel in Switzerland and his colleagues conducted the first ever randomised controlled trial of LSD microdosing for ADHD. They recruited 53 adults living in ...